INNV-16. CLINICAL APPLICABILITY OF INDIVIDUALIZED DRUG RESPONSE PROFILING UTILIZING EX-VIVO TISSUE-DERIVED 3D CELL CULTURE ASSAYS IN HIGH-GRADE GLIOMA: A SINGLE INSTITUTION CASE SERIES USING 3D-PREDICT RESULTS

Recurrent high-grade glioma is a challenging disease process, without consensus on effective second-line therapy options. Individualized, patient-specific, biologically-based data is desirable in driving therapeutic decision-making. Patients with recurrent high-grade glioma and planned surgical re-r...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Neuro Oncol
Autores principales: Lipinski, Lindsay, Abad, Ajay, Mechtler, Laszlo, Fabiano, Andrew, Smith, Ashley, DesRochers, Teresa, Gevaert, Matthew, Vibat, Cecile Rose, Fenstermaker, Robert
Formato: Artigo
Lenguaje:Inglês
Publicado: Oxford University Press 2020
Materias:
Innovations in Patient Care
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC7651647/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noaa215.499
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares